Shots:
The US FDA has approved integrated sacral neuromodulation (iSNM) system to treat urinary urge incontinence (UUI)
iSNM device was evaluated in a P-II trial in 128 pts, which showed 84.2% pts achieved ≥50% reduction in urgent leaks, with 84% & 42% responders experiencing >75% & 100% reduction, respectively in UUI symptoms at 6mos.; 3.5x…
